All posts by imreal

Olney Center for Oral and Maxillofacial Surgery Introduces New Technology For Wisdom Tooth Removal Procedures


Carestream Dental’s CS 9600 CBCT

Carestream Dental’s CS 9600 CBCT

“I’m always on the hunt for new technologies, new methods, new advancements‒ absolutely anything that can give our patients the best-possible outcomes and make them more comfortable during whatever procedure they come in for.” — Dr. Tebyanian, President, Olney Center For Oral & Maxillofacial Surgery

Every year, approximately 5 million Americans have their wisdom teeth removed. Maryland-based Olney Center for Oral and Maxillofacial Surgery announces the addition of state-of-the art technology to their practice for the removal of wisdom teeth. This innovative imaging technology, Carestream Dental’s CS 9600 CBCT (Cone-beam computed tomography) Scanner, makes these procedures safer and reduces the risk of nerve damage for their patients.

According to the U.S. Food & Drug Administration, (CBCT) cone-beam computed tomography systems are a variation of traditional (CT) computed tomography systems. The CBCT systems used by dental professionals rotate around the patient, capturing data using a cone-shaped x-ray beam. The data is used to reconstruct a three-dimensional (3D) image of the following regions of the patient’s anatomy: dental (teeth); oral and maxillofacial region (mouth, jaw and neck); and ears, nose, and throat.

The new CS 9600 CBCT Scanner offers a number of benefits to both the dental team and the patients at Olney Center for Oral and Maxillofacial Surgery.

  • Shows the exact location of nerves to reduce risk of nerve damage
  • Ability to construct 3D images of teeth and the entire maxillofacial region (mouth, jaw, and neck)
  • AI-powered positioning to get consistent results effortlessly
  • Crystal-clear, high-resolution images
  • Minimal radiation exposure
  • Broadest range of volume sizes, with up to 14 FOV (fields of view)

Dr. Anis Tebyanian, President of Olney Center For Oral and Maxillofacial Surgery, is a highly regarded, board-certified Oral and Maxillofacial Surgeon who specializes in oral and maxillofacial surgery, anesthesia, general surgery, plastic surgery, head and neck surgery, and facial trauma.

“I am always on the hunt for new technologies, new methods, new advancements‒ absolutely anything that can give our patients the best-possible outcomes and make them more comfortable during whatever procedure they come in for.” – Dr. Anis Tebyanian, President of Olney Center For Oral and Maxillofacial Surgery

Dr. Tebyanian and his team are very proactive in implementing the latest advancements in Oral and Maxillofacial surgery to offer the most-effective treatments available. He sees the addition of the CS 9600 CBCT Scanner as an important tool in providing optimal health for his patients.

The Olney Center For Oral and Maxillofacial Surgery has been in existence for more than 20 years. Dr. Anis Tebyanian and his team are dedicated to delivering outstanding care in a comfortable, patient-centric environment. Dr. Tebyanian has a dual degree. He is a board-certified Oral and Maxillofacial Surgeon. He is licensed as a Dentist and a Surgeon Physician in the state of Maryland.

To learn more about the CS 9600 CBCT Scanner and its use in Wisdom Tooth Extraction, contact Olney Center For Oral and Maxillofacial Surgery.

Share article on social media or email:

Author, Entrepreneur and Philanthropist Announces Kehoe Family Foundation Website and Mayo Clinic Support


Kevin and Lorraine Kehoe are the Kehoe Family Foundation Founders, whose multi-generational team supports charities coast-to-coast, including the Mayo Clinic in Arizona.

We want to teach future generations of Kehoes the importance of ‘giving back’, and learning that idea early in life. We look for organizations where we can make a significant impact by giving both our time and money. – Kevin R. Kehoe, Kehoe Family Foundation Founder

Aspire Software Founder, Author (“One Hit Wonder”) and Stage 4 Cancer Survivor Kevin R. Kehoe officially announces the launch of The Kehoe Family Foundation website (https://kehoefamilyfoundation.org) and support for charities coast-to-coast, including efforts to increase patient access to cutting-edge cancer treatments at the Mayo Clinic in Arizona.

Founder and Philanthropist Kevin R. Kehoe was diagnosed with Stage 4 cancer shortly after he started the Aspire Software company in 2014. Kevin was given a 30 percent three-year survival prognosis, and is grateful to the Mayo Clinic team in Phoenix, Arizona, and his first oncologist Dr. Tara Seery in Laguna Beach, California, for their support and care for the past eight years. While building Aspire Software into a scalable business, Kevin survived seven surgeries, five courses of radiation, and months and months of chemo. When he asked Dr. Seery why she thought he was still alive when others diagnosed with him had passed away, she said, “You’re lucky. Your cancer is probably what we call a ‘good actor’…that’s my best assessment.”

After Kevin R. Kehoe’s company was fully acquired in 2021, he wrote a book “One Hit Wonder” to help fellow entrepreneurs and others succeed in pursuing their dreams. In addition, Kevin and his family members, set up a philanthropic foundation in 2021 with the idea that the next generations of Kehoes would be involved in giving to causes aligned with the family’s values.

As the grandson of Irish immigrants and oldest of six children, Kevin’s new foundation’s Mission is to: “Engage future generations of Kehoe family members in being actively involved in responsible giving to organizations that support the Founder’s values and causes.” Kevin explained: “We want to teach future generations of Kehoes the importance of ‘giving back’, and learning that idea early in life. We look for organizations where we can make a significant impact by giving both our time and money.”

The core members of The Kehoe Family Foundation include the two Founders Kevin and his wife Lorraine Kehoe, along with Julia M. Kehoe (Kevin’s daughter), Michael Kehoe (Kevin’s brother), Deirdre Chanis (Kevin’s sister and her two boys – Kevin’s nephews), and Matt Kehoe (Kevin’s nephew).

As a Stage 4 Cancer survivor, Kevin felt strongly about supporting community outreach and engagement through Mayo Clinic Comprehensive Cancer Center in Arizona. This includes efforts to increase clinical trial access to cutting-edge cancer therapies and establishing a patient navigation program that decreases barriers for patients and their families to improve their care and overall experience.

Kevin expanded, “We are happy to announce that the new Kehoe Family Fund for Cancer Community Outreach and Engagement has been set up at Mayo Clinic in Arizona and honors Tanios Bekaii-Saab, M.D., a physician who works with patients needing specialized cancer care.”

Along with Mayo Clinic, The Kehoe Family Foundation current beneficiaries include Hillsdale College, SUNY Stony Brook Athletics, Tunnel to Towers, Turning Point USA and the National Association of Landscape Contractors.

In his leadership book, “One Hit Wonder”, Kevin R. Kehoe shares his inspiring life and business lessons to help readers succeed in an entertaining storytelling format. Kevin emphasizes, “It can take years to achieve a defining moment of success. For many ‘One Hit Wonders’, like musicians, one success does not define their life or legacy. The real story about a one hit wonder is the focus on a lifetime body of work, plus the good fortune of having one mega hit that will always be special and memorable.”

Or as Kehoe states; “We all dream of being ‘Superman’. But for me Superman’s story and his greatest contribution has never been the superhero part… it’s the Clark Kent part – the idea that any of us, in all our ordinariness, can change the world.”

And with millions of students going back to school this August, Kevin R. Kehoe encourages them to learn more about giving time and money to organizations that support their values and how they want to make the world a better place.

BOOK on AMAZON

“One Hit Wonder: The Real-Life Adventures of an Average Guy and the Lessons He Learned Along the Way” (2021) by Kevin R. Kehoe

https://www.amazon.com/dp/B09JFC26LZ/ref=dp-kindle-redirect?_encoding=UTF8&btkr=1

MEDIA CONTACT:

Liz Kelly, 310-987-7207

ABOUT: Kevin R. Kehoe (Scottsdale, Arizona, born in New York, New York) is an inspiring Author (“One Hit Wonder”), Aspire Software Co-Founder, Entrepreneur, Philanthropist (The Kehoe Family Foundation), and Stage 4 Cancer Survivor, who was born and raised in New York City, and lived most of his life in Southern California with stops in Florida and Texas, along the way. After doing small business consulting for 30 years, Kehoe’s personal “One Hit Wonder” was co-founding Aspire Software in 2013, which was sold in 2021 to ServiceTitan. Kehoe is the grandson of Irish immigrants, oldest of six children, who has survived catholic schools and nuns, two marriages, six job terminations, motorcycle crashes, and Stage 4 cancer. His life experiences have included being an altar boy, choir boy, business consultant and entrepreneur, motorcycle racer, surfer and marathon runner. As a graduate of SUNY Stony Brook, Southern Methodist University and ASU Thunderbird School, Kehoe now lives in Arizona with his wife, Lorraine. Kevin has one daughter, who lives in St. Louis. As fun facts, Kevin likes coffee in the morning and tequila in the evening. His personal goal and mission for “One Hit Wonder” is to “leave the earth a better place than I entered it.” His work has been featured in Fast Company, Real Leaders, Authority Magazine, BookLife, School of Startups, and many podcasts. For more information, follow Author Kevin R. Kehoe and visit https://onehitwonder.site

and https://kehoefamilyfoundation.org.

Share article on social media or email:

Dr. Janet M. Neigel of Eltra Self Awarded As NJ Top Doc For 2022


Dr. Janet M. Neigel

NJ Top Docs has reviewed and approved board certified ophthalmologist, Dr. Janet M. Neigel of Eltra Self for 2022. Dr. Neigel’s Florham Park based facial plastic surgery practice offers both surgical and non-invasive treatments and procedures to help keep you looking more youthful.

Dr. Neigel received both her undergraduate and medical degrees in New Jersey. She graduated with honors in biology from Douglass College, Rutgers University, and obtained her M.D. degree from UMDNJ-New Jersey Medical School, where she completed her ophthalmology specialty residency training.

Prior to obtaining her degree, Dr. Neigel spent 2 years training in Far Eastern University Manila in the Philippines. She completed an orbital and oculofacial plastic surgery fellowship at the University of British Columbia, Vancouver, Canada and is licensed in New Jersey, New York and Florida.

Dr. Neigel has presented research at the Academy of Ophthalmology and other major affiliations and meetings. She has received several awards, including the American Medical Association Physician Recognition Award and the American Academy of Ophthalmology Achievement Award.

Currently, Dr. Neigel is a member of the surgical staff at the following hospitals and surgicenters:


  • Livingston Surgery Center
  • Eltra Surgery Center, Florham Park, NJ
  • St. Barnabas Medical Center, Livingston, NJ
  • Morristown Medical Center, Morristown, NJ
  • Rutgers UMDNJ-University Hospital, Newark, NJ
  • Ridgedale Surgery Center

To learn more about Dr. Janet M. Neigel, please visit: https://njtopdocs.com/nj-doctors/drjanetneigel/

—-

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



HashCash Offers Blockchain Traceability Solutions to a Major US Pharma Company


Hashcash blockchain solutions to a major US pharma company

Hashcash blockchain solutions to a major US pharma company

Blockchain has proved its utility as an indispensable technology implemented across some of the biggest global supply chains. The platform powering Bitcoins ensures transparency and traceability throughout the entire process, offering real-time visibility for informed decision-making.

Global blockchain development company HashCash Consultants added another achievement to its growing list of accolades. The company declared a collaboration with a multinational US pharma corporation, where the former will be offering its blockchain expertise for improving traceability and streamlining medical supply chains.

Blockchain has been a game changer across medical supply chains where traceability and provenance are crucial. Medical components can be hazardous if they exceed their expiry date, or are not kept under prescribed storage conditions. Blockchain’s time-stamped transaction record-keeping is utilized by several pharma giants to optimize their existing operations, guaranteeing component sources from manufacturing to distribution and beyond.

HashCash CEO and blockchain pioneer Raj Chowdhury states, “Blockchain has proved its utility as an indispensable technology implemented across some of the biggest global supply chains. The platform powering Bitcoins ensures transparency and traceability throughout the entire process, offering real-time visibility for informed decision-making.”

In addition to medical supply and storage, blockchain has been extensively used in global vaccination drives, particularly during the recent worldwide pandemic. While the whole word focused on isolation and avoiding getting infected by COVID-19, blockchain reinforced the process, minimizing interaction by eliminating intermediaries for documentation. They were also critical in preserving the efficacy of these vaccines.

“Blockchain remains one of the biggest revelations in the current digital revolution. From powering innovations of the future to improving functions in the existing structure, the technology will benefit billions by promoting financial inclusion, equality, and productivity,” concluded Chowdhury, who had previously expressed his support for blockchain use in education management and reduction of carbon emissions.

Based out of the US, HashCash has won top honors in global blockchain development. Deploying products in over 26 countries across 6 continents, the company has been consistent in surpassing client expectations and prioritizing innovation and excellence. HashCash has been well-versed with blockchain consortium, IoT, supply chain, and traceability solutions have partnered with enterprises across the US, Spain, Europe, and more. The firm has also been involved in building blockchain prototypes for vaccine distribution, prevention of drug fraud, child trafficking, and more.

Blockchain’s undeniable contribution across any domain that requires documentation and subsequent validation has driven its implementation across major supply chains of the world, including case-sensitive pharma companies. Enterprises can integrate the technology to leverage better business growth opportunities through optimization of processes and subsequent cost-cutting.

  • About HashCash Consultants:


HashCash is a global software company. HashCash Blockchain products enable enterprises to move assets and settle payments across borders in real-time for Remittances, Trade Finance, Payment Processing, and more. HashCash runs a US-based digital asset exchange, PayBito & digital asset payment processor, BillBitcoins. HashCash offers white label crypto exchange and payment processor software solutions, ICO services, and customized use cases. HashCash propels advancement in technology through Blockchain1o1 programs and its investment arm, Satoshi Angels. HashCash offers solutions in AI, Big Data, and IoT through its platforms, products & services. HashCash solves the toughest challenges by executing innovative digital transformation strategies for clients around the world.

Share article on social media or email:

Genomenon Partners with Rady Children’s Institute for Genomic Medicine on Newborn Screening by Next Generation Sequencing


News Image

“Genomenon’s essential role in curating actionable genomic information and making it easily accessible to these professionals is helping transform [our] goal into a reality.” – Dr. Stephen Kingsmore, President & CEO, Rady Children’s Institute for Genomic Medicine

Genomenon, Inc., an AI-driven genomics company, announced a partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) that will help clinicians make better diagnosis and treatment decisions. Genomenon will fully curate all genes included in RCIGM’s recently announced BeginNGS™ (pronounced “beginnings”) newborn screening panel and deliver comprehensive data on disease-causing variants within these genes. The goal of BeginNGS is to improve infant patient outcomes by providing clinicians with powerful insight on both how these diseases form and how to treat them.

As one of the most successful public health programs in the United States, newborn screening tests 98 percent of the nearly 4 million babies born annually. However, of the hundreds of childhood genetic diseases with available treatments, a small portion—typically up to 50—are included in this screening. And adding a new disease to the screening protocol is labor-intensive, expensive, and slow. For each condition, the process takes close to five years.

BeginNGS uses RCIGM’s rapid whole genome sequencing (rWGS®) to diagnose genetic diseases and identify potential treatment options for children while they are asymptomatic. Once patients are diagnosed, a virtual patient care guidance tool called Genome-to-Treatment (GTRx™) helps clinicians understand genetic conditions and access available treatment options.

As part of their mission to curate the entire human genome, Genomenon combines AI-powered genomics with expert review to curate all the variants that have been published in all the genes in the BeginNGS screening panel—genes tied to over 400 diseases. Genomenon then provides a comprehensive, actionable dataset for the variants that are found to cause disease. The ability to put this information in the hands of clinicians with speed and accuracy—and at an early stage in life—is an inspiring step forward in the mission to diagnose and treat life-threatening rare diseases before they cause irreversible damage.

“The goal of BeginNGS and GTRx is to help ensure each baby is screened for treatable genetic conditions, and to help physicians provide effective treatment in a timely manner,” said Dr. Stephen Kingsmore, President & CEO, Rady Children’s Institute for Genomic Medicine. “Genomenon’s essential role in curating actionable genomic information and making it easily accessible to these professionals is helping transform that goal into a reality.”

“We are excited to announce our partnership with Rady Children’s Institute for Genomic Medicine to diagnose and treat critically ill babies with genetic diseases,” said Mike Klein, CEO of Genomenon. “By screening for over 400 treatable conditions and providing treatment guidelines to doctors and other clinicians before symptoms start, BeginNGS is creating life-saving opportunities for patients and their families at very early stages. Genomenon is honored to play a part in this important mission.”

About Genomenon

Genomenon is an AI-driven genomics company focused on the advancement of positive health outcomes for patients with rare genetic diseases and cancer. Keeping pace with the ever-evolving body of knowledge within genomics, Genomenon connects current research with patient DNA to accelerate clinical decision making and pharmaceutical drug discovery.

For more information, visit Genomenon.com

Share article on social media or email:

Daniele Severi Bruni Joins Stratevi as Chief Access Officer to Expand the Growth of the Firm in Pricing and Market Access


Daniele Severi Bruni

At Stratevi, we look forward to partnering with our clients to develop evidence-supported value and access strategies.

Stratevi LLC, a boutique health economics, outcomes research, and market access consulting firm, announces the appointment of Daniele Severi Bruni, MS, to the newly created role of Chief Access Officer. Mr. Severi Bruni will focus on expanding the firm’s capabilities and service offerings in strategic pricing and market access. He will be based in Santa Monica, California, and report to Josh Epstein, PhD, Chief Executive Officer.

With Mr. Severi Bruni joining alongside Matthew Sussman, Stratevi doubled its leadership team in 2022, and is now able to more comprehensively address its clients’ needs.

“As we celebrate our 7th anniversary, we are thrilled to have Daniele bring to the team a highly specialized and complementary set of skills, which will strengthen Stratevi’s value proposition,” said Dr. Epstein.

Mr. Severi Bruni also commented that, “it is extremely exciting to join this team of talented health economists. I am honored to have the opportunity to develop a new set of integrated services, designed to deliver strong and actionable market access solutions. Too often market access consulting groups lose sight of the actual evidence that is needed to successfully implement their recommendations. At Stratevi, we look forward to partnering with our clients to develop evidence-supported value and access strategies.”

Daniele Severi Bruni brings over 22 years of experience in academia and management consulting. For the past 15 years Daniele has focused on pricing & market access and payer strategy. He has worked both in Europe and the US. He has in-depth knowledge of both European HTAs and US Managed Markets, as well as a robust network of payers and expert advisers. Daniele has worked across many disease areas, and he has been part of the market access launch readiness teams for several large and small drug manufacturers. Daniele holds a degree in Business and Economics and Master of Technology and Innovation Management from Bocconi University, in Milan.

About Stratevi®

Stratevi is a boutique professional services firm that partners with pharmaceutical, biotech, and medical device manufacturers to strategically generate and creatively communicate evidence of product value to ensure optimal access to therapy and enhance health outcomes. Stratevi has developed several differentiated products and services, including StrateLaunch™, StratePulse®, StrateReview™, StrateVision®, and StratePlay®. Stratevi has offices in both Santa Monica, CA, and Boston, MA. To learn more, please visit http://www.stratevi.com or connect via LinkedIn.

Share article on social media or email:

VA Palo Alto cuts the ribbon on new Basic Science Research Center


VA executive leadership cuts the ribbon on the new Basic Science Research Center at VA Palo Alto.

VA executive leadership cuts the ribbon on the new Basic Science Research Center at VA Palo Alto.

On July 28, 2022, VA Palo Alto Health Care System (VAPAHCS) held a ribbon cutting ceremony for a new Basic Science Research Center at its Palo Alto Campus. The health care system hosted several executives from VA, including Chief Research and Development Officer, Office of Research and Development Dr. Rachel Ramoni and Assistant Under Ssecretary for Health, Discovery, Education and Affiliate Networks Dr. Carolyn Clancy.

“It’s a very exciting time to be at VA, in VA research and most specifically, at VA Palo Alto Health Care,” said Dr. Clancy, who gave the keynote remarks at the ceremony and spent the day learning about all the great initiatives underway at VAPAHCS.

Those in attendance also heard remarks from VAPAHCS’ Director Lisa Howard, Associate Chief of Staff for Research Dr. Jennifer Lee, Chief of Staff Dr. Michael Kozal, Dr. Lloyd Minor, Dean of Stanford University School of Medicine, and Dr. Ramoni also gave remarks at the event. Color guard was provided by the United States Marine Corps Recruiting Station San Francisco with the national anthem sung by Jamie Wong.

“The collaborative effort of VA, Stanford and our research community is what really made this possible, and we could not be more grateful as the building allows for continued growth to expand our investigation to serve the future of health for our Veterans and for all of our communities,” said Director Howard.

The building first broke ground in 2016. From the patterns inspired by DNA sequencing on the building’s exterior to the dramatic two-story water-themed tapestry in the lobby, the design of this new Basic Science Research Center provides a welcoming environment for researchers while inspiring new medical advancements.

The tapestry also serves as a sound baffle for the lobby of the two-story, 95,000 gross square foot building which also features an underground vivarium that is almost twice the square footage of the laboratory floors above. Sections of the subterranean levels have “green roofs,” which serve as patio and garden spaces on the ground floor.

On the first and second floors, Principal Investigators have office suites along the west side of the building with access to 6,400 square feet of open labs, each containing 56 benches that have a “quick disconnect” capability for easy reconfiguration.

There are conference rooms on each floor to further encourage collaboration, along with casual “break out” spaces provided in the glazed corridor along the building’s south side. These spaces include both seating and whiteboards. The building also features a utility level of approximately 31,000 gross square feet and a loading dock.

The state-of-the-art facility was designed to foster collaboration and knowledge sharing among world-class researchers, reinforcing VA Palo Alto as one of the top three research programs in the Veterans Health Administration with annual funding of approximately $70 million. Currently, there are 718 active research projects that are being conducted by approximately 300 Principal Investigators with nearly 1,700 research staff.

VAPAHCS is home to a variety of National VHA Research Centers and programs, which are home to world-renowned scientists who have received notable awards including, but not limited to the 2021 Under Secretary’s Award for Outstanding Achievement in Health Services Research, 2021 HSR&D Best Research Paper of the Year Award, and a Nobel Laureate in Medicine. In addition to these awards, nearly a thousand papers are published each year.

Click here to view the video and view photos on Flickr commemorating this special event!

Share article on social media or email:

Collins Price, PLLC Celebrates Ten Year Anniversary in Winston-Salem


“Despite the challenges any small business faces, we’ve been able to steadily grow our service area without compromising the quality of service we offer our clients.”

Brad Collins and Andrew Price, founders of Winston-Salem Social Security Disability law firm Collins Price, PLLC, announced the firm will celebrate a decade in business this month.

Attorneys Collins and Price are experienced Social Security Disability lawyers who first met as law students at Wake Forest University’s School of Law and then later worked for a similar disability law firm before leaving to found their own. The partners founded Collins Price, PLLC on August 17, 2012 in Winston-Salem.

“Founding the business in Winston-Salem made a lot of sense for us. We had access to excellent office space, reasonable rent, an adequate customer base and close proximity to other cities throughout the greater Piedmont Triad and Charlotte-metro areas,” said Attorney Collins.

Since their founding, Collins Price has added three physical locations and additional service areas to serve clients throughout North Carolina.

“Despite the challenges any small business faces, we’ve been able to steadily grow our service area without compromising the quality of service we offer our clients,” said Attorney Price. “Our very first hire is still with us and helped us build out a strong support team of Case Managers along the way.”

Collins Price, PLLC has almost 180 five-star reviews on Google. The firm wishes to thank the thousands of Winston-Salem clients and their families who trusted the firm with their Social Security Disability claim over the last 10 years.

About Collins Price, PLLC

Collins Price, PLLC is a Social Security Disability law firm founded by Attorneys Brad Collins and Andrew Price in 2012. Both partners met at Wake Forest University where they attended law school. Collins Price, PLLC focuses on the practice of Social Security Disability Law, serving clients seeking or appealing denied benefits for the federal Supplemental Security Income (SSI) and Social Security Disability Insurance (SSDI) programs. Collins Price, PLLC serves claimants throughout North Carolina. For more information, please visit us online.

Share article on social media or email:

The TLC Foundation for Body-Focused Repetitive Behaviors Celebrates August’s National Hair Loss Awareness Month


News Image

“There are so many misconceptions around body-focused repetitive behaviors, which is why they go misdiagnosed, underreported and understudied,” said Dr. John Piacentini, Professor of Psychiatry and Biobehavioral Sciences at UCLA, TLC Board President and Scientific Advisory Board Chair.

The TLC Foundation for Body-Focused Repetitive Behaviors (BFRBs) is sharing its support of National Hair Loss Awareness Month celebrated in August. Over 80 million individuals experience hair loss every year, with 40% of those experiencing hair loss being women. Individuals who experience hair loss can also include those who have a BFRB called trichotillomania, also known as hair pulling disorder.

Hair pulling disorder usually begins in late childhood/early puberty and occurs about equally in boys and girls. By adulthood, 80-90% of reported cases are women. Hair pulling varies greatly in its severity, location on the body, and response to treatment. Without treatment, hair pulling disorder tends to be a chronic condition; that may come and go throughout a lifetime.

The TLC Foundation for Body-Focused Repetitive Behaviors is bringing awareness and support to an underreported and misunderstood group of mental health disorders that impacts approximately one in 20 Americans, with hair pulling being one of the most prevalent. Body-Focused Repetitive Behaviors are complex medical diagnoses that affect children and adults alike, and often cause shame, isolation, and emotional distress. Yet despite their prevalence, these behaviors are rarely discussed in the general public.

“There are so many misconceptions around body-focused repetitive behaviors, which is why they go misdiagnosed, underreported and understudied,” said Dr. John Piacentini, Professor of Psychiatry and Biobehavioral Sciences at UCLA, TLC Board President and Scientific Advisory Board Chair. “They are often dismissed as bad habits or categorized as self-harming rituals, which they are not. There are tremendous consequences for not acknowledging these behaviors or misdiagnosing them, including depression, anxiety, and suicide for those affected.”

Fortunately, the stigma and shame around these behaviors is starting to change, thanks in part to recent advocacy by comedian, writer, and actress Amy Schumer, who has experienced hair pulling since she was a child. In episode 9 of her Hulu dramedy, “Life & Beth,” which is based on her own life, she wrote an accurate portrayal of hair pulling in a flashback to her teenage years. At the end of the Hulu episode, viewers were directed to TLC Foundation’s website as a resource for support and information.  

National Hair Loss Awareness Month further allows others to learn about hair loss and to lessen the shame that comes with losing hair for any reason. In addition, this month allows a period of reflection in regard to traditional beauty standards with hair.

In August, TLC is hosting a series of free, online events tailored to a variety of audiences to help destigmatize hair pulling and other associated behaviors, share resources and support, answer questions through medical experts, build community, and provide a pathway forward to managing these conditions. Visit TLC’s website for times and details at http://www.bfrb.org.

August 15     TLC Together: BFRB Brave Books

August 24     TLC Talks: Back to School with BFRBs

About the TLC Foundation for Body-Focused Repetitive Behaviors

The TLC Foundation for Body-Focused Repetitive Behaviors is a 501(c)3 health-related human services organization dedicated to supporting the 1-in-20 individuals experiencing body-focused repetitive behaviors (BFRBs) through advocacy, awareness, connection, health education, celebration, and equitable access to effective evidence-based treatments. To learn more, visit http://www.bfrb.org.

###

FAQs about Hair Pulling or Trichotillomania

What is hair pulling or trichotillomania?

  • Hair pulling disorder or trichotillomania (trick-o-till-o-may-nee-uh) (TTM or “trich”) is characterized by the repetitive pulling out of one’s hair. Hair pulling disorder is one of a group of behaviors known as body-focused repetitive behaviors (BFRBs), self-grooming behaviors in which individuals pull, pick, scrape, or bite their hair, skin, or nails, resulting in damage to the body.
  • Research indicates that approximately 1 or 2 in 50 people experience hair pulling disorder in their lifetime. Hair pulling disorder usually begins in late childhood/early puberty and occurs about equally in boys and girls. By adulthood, 80-90% of reported cases are women. Hair pulling varies greatly in its severity, location on the body, and response to treatment. Without treatment, hair pulling disorder tends to be a chronic condition; that may come and go throughout a lifetime.

What are signs and symptoms of hair pulling?

  • Hair pulling disorder is currently classified under Obsessive-Compulsive and Related Disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

The DSM-5 diagnostic criteria include:

  • Recurrent hair pulling, resulting in hair loss
  • Repeated attempts to decrease or stop the behavior
  • Clinically significant distress or impairment in social, occupational, or other area of functioning
  • Not due to substance abuse or a medical condition
  • (e.g., dermatological condition)
  • Not better accounted for by another psychiatric disorder

When does hair pulling take place?

  • Hair pulling may occur across a variety of settings and both sedentary and active activities. There are times when pulling occurs in a goal-directed manner and also in an automatic manner in which the individual is less aware. Many individuals report noticeable sensations before, during, and after pulling. A wide range of emotions, spanning from boredom to anxiety, frustration, and depression can affect hair pulling, as can thoughts, beliefs, and values.

Does everyone with hair pulling experience hair loss?

  • Although the severity of hair pulling varies widely, many people with hair pulling or trichotillomania have noticeable hair loss, which they attempt to camouflage. Thinning or bald spots on the head may be covered with hairstyles, scarves, wigs, or makeup. Those with missing eyelashes, eyebrows, or body hair, may attempt to camouflage with makeup, clothing, or other means of concealing affected areas.

What are some effects of hair pulling?

  • Due to shame and embarrassment, individuals not only try to cover up the effects of hair pulling, but may avoid activities and social situations which may lead them to feel vulnerable to being “discovered” (such as windy weather, going to the beach, swimming, doctor’s visits, hair salon appointments, childhood sleepovers, readying for bed in a lighted area, and intimacy).

What treatments are available for hair pulling?

  • There is no cure, but improvement is possible. Although no one treatment has been found to be effective for everyone, a number of evidence-based psychotherapeutic treatment options including cognitive behavioral therapy are successful for some.

To learn more about hair pulling and other body-focused repetitive behaviors, download TLC’s Expert Consensus Treatment Guidelines: https://www.bfrb.org/storage/documents/Expert_Consensus_Treatment_Guidelines_2016w.pdf

Subject Matter Experts

The TLC Foundation offers the following subject matter experts for media interviews.

To schedule an interview, please contact:

Jen Monteleone, Interim Executive Director

E: jmonteleone@bfrb.org

P: 831-457-1004 ext. 1

Research:

  • Dr. John Piacentini, TLC Board President & TLC Scientific Advisory Chair, UCLA
  • Dr. Nancy Keuthen, Massachusetts General Hospital/Harvard Medical School
  • Dr. Jon Grant, University of Chicago
  • Dr. Darin Dougherty, Massachusetts General Hospital/Harvard Medical School
  • Dr. Doug Woods, Marquette University
  • Dr. Marty Franklin, University of Pennsylvania School of Medicine
  • Dr. Tara Perris, UCLA
  • Dr. Emily Ricketts, UCLA

Medicine:

  • Dr. Jon Grant, University of Chicago
  • Dr. Darin Dougherty, Massachusetts General Hospital/Harvard Medical School

Treatment:

  • Dr. John Piacentini, TLC Board President & TLC Scientific Advisory Chair, UCLA
  • Dr. Suzanne Mouton-Odum, Psychology Houston, PC
  • Dr. Nancy Keuthen, Massachusetts General Hospital/Harvard Medical School
  • Dr. Charles Mansueto, Behavior Therapy Center of Greater Washington
  • Dr. Fred Penzel, Western Suffolk Psychological Services
  • Ruth Golomb, Behavior Therapy Center of Greater Washington
  • Dr. Doug Woods, Marquette University
  • Dr. Marty Franklin, University of Pennsylvania School of Medicine
  • Dr. Tara Perris, UCLA
  • Dr. Emily Ricketts, UCLA

Share article on social media or email:

Jump Technologies to showcase new Virtual Pick List solution at AHRMM22, August 7-10 in Anaheim


Virtual Pick List screen capture.

Source: Jump Technologies.

Jump Technologies, a leading hospital supply chain solutions and analytics company, will be providing demonstrations of its new, patent-pending Virtual Pick List technology – along with its full suite of hospital supply chain solutions – at booth 244 during AHRMM22 Conference and Exhibition August 7-10 in Anaheim, CA. The Virtual Pick List uses machine learning algorithms to deliver real-time data that can help nurses and supply chain staff automate and simplify the cleaning of physician preference cards, a task that is time consuming, frustrating, and never ending for nursing staff.

Jump Technologies delivers a full suite of dock-to-patient solutions that empower hospitals to reduce waste and save money, stop stock outs that put patients and staff at risk, and streamline workflows for overworked clinical and supply chain staff.

  • Virtual Pick List uses patent-pending machine learning algorithms to analyze case data from a hospital’s electronic medical record system and identify changes to the case pick list that reflect what physicians actually use during procedures.
  • The Virtual Pick List is printed prior to a case with clearly marked suggestions for items that should not be picked, changes to open and hold quantities, and items that should be picked that are not currently on the preference card.
  • The person picking the case can choose to follow the items and quantities suggested by Virtual Pick List, or to pick items as per the original pick ticket.

The Virtual Pick List is available as a standalone solution and can be used in conjunction with the full suite of solutions from Jump Technologies, including the JumpStock inventory management platform and Case Companion for procedure suites. To schedule a demonstration of the Virtual Pick List at AHRMM22, visit JumpTech.com.

###

About Jump Technologies

Headquartered in Eagan, MN, Jump Technologies creates safe, simple, and cost-effective solutions that help hospitals reduce stock outs, overordering, and waste, while increasing inventory turns and improving billing accuracy across a facility or system. The company’s JumpStock solution facilitates data-driven decision making that allows hospitals to save time, free up cash, and improve nurse satisfaction with supply chain. To learn more, visit JumpTech.com or call (888) 373-7226. Follow Jump Technologies on LinkedIn and Twitter @JumpTechNews.

Media contact: Barbara Tabor, APR / (651) 230-9192 / barbara@taborpr.com

Share article on social media or email: